Literature DB >> 32360508

Analysis of articles directly related to randomized trials finds poor protocol availability and inconsistent linking of articles.

David Sender1, Justin Clark1, Tammy C Hoffmann2.   

Abstract

OBJECTIVES: Interpreting a randomized trial requires access to more than the main results paper. We aimed to determine the (1) proportion of trials referring to the protocol in the trial report and their accessibility, (2) proportion of protocols accessible from trial registry entry and by trial registration number search, and (3) types of additional publications associated with trial reports. STUDY DESIGN AND
SETTING: A previously gathered sample of randomized trials of nonpharmacological interventions published in 2009 was used. Trial reports and registry entries were searched for protocol mentions and obtained when possible. Related publications were identified using citation searching.
RESULTS: Of 133 trials, 96 (72%) mentioned the protocol within the report, 61 (64%) contained details about protocol acquisition, with 48 (36%) protocols obtainable. Of the 129 registered trials, 32 (25%) had protocols obtainable from registry entry. Citation tracking identified 1,030 related publications, most common were secondary analyses and qualitative studies.
CONCLUSION: Trial protocols facilitate good trial conduct and interpretation. However, they are often not linked to the main report or registry and can be difficult to obtain. Many trials have related publications that are inconsistently linked. Trial registries and registration numbers could facilitate the threading of articles related to a trial, but currently do not.
Copyright © 2020 Elsevier Inc. All rights reserved.

Keywords:  Protocol; Randomized controlled trial; Records; Registries; Trial registration

Mesh:

Year:  2020        PMID: 32360508     DOI: 10.1016/j.jclinepi.2020.04.017

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  4 in total

1.  The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.

Authors:  Rafael Dal-Ré
Journal:  Eur J Clin Pharmacol       Date:  2020-10-26       Impact factor: 2.953

Review 2.  A review identified challenges distinguishing primary reports of randomized trials for meta-research: A proposal for improved reporting.

Authors:  Stuart G Nicholls; Steve McDonald; Joanne E McKenzie; Kelly Carroll; Monica Taljaard
Journal:  J Clin Epidemiol       Date:  2022-01-23       Impact factor: 7.407

3.  Access to unpublished protocols and statistical analysis plans of randomised trials.

Authors:  Vipul Jairath; Brennan C Kahan; David Campbell; Cassandra McDonald; Suzie Cro
Journal:  Trials       Date:  2022-08-17       Impact factor: 2.728

4.  A longitudinal assessment of trial protocols approved by research ethics committees: The Adherance to SPIrit REcommendations in the UK (ASPIRE-UK) study.

Authors:  Benjamin Speich; Ayodele Odutayo; Nicholas Peckham; Alexander Ooms; Jamie R Stokes; Ramon Saccilotto; Dmitry Gryaznov; Belinda von Niederhäusern; Bethan Copsey; Douglas G Altman; Matthias Briel; Sally Hopewell
Journal:  Trials       Date:  2022-07-27       Impact factor: 2.728

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.